These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17504366)

  • 1. Adjunctive zonisamide for treatment refractory anxiety.
    Kinrys G; Vasconcelos e Sa D; Nery F
    Int J Clin Pract; 2007 Jun; 61(6):1050-3. PubMed ID: 17504366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
    Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
    Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early response and 8-week treatment outcome in GAD.
    Rynn M; Khalid-Khan S; Garcia-Espana JF; Etemad B; Rickels K
    Depress Anxiety; 2006; 23(8):461-5. PubMed ID: 16845651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
    Malhi GS; Ng F; Berk M
    Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine treatment of generalized anxiety disorder: a fixed dose, open label study.
    Gambi F; De Berardis D; Campanella D; Carano A; Sepede G; Salini G; Mezzano D; Cicconetti A; Penna L; Salerno RM; Ferro FM
    J Psychopharmacol; 2005 Sep; 19(5):483-7. PubMed ID: 16166185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of sustained release of alprazolam: A naturalistic study].
    De La Gándara Martín JJ; Sanz Granado O; Varona Martínez A; Such P
    Actas Esp Psiquiatr; 1999; 27(3):191-7. PubMed ID: 10431062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R; Sartori VA; Seabra ML; Leite JR
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study.
    Wang PW; Yang YS; Chandler RA; Nowakowska C; Alarcon AM; Culver J; Ketter TA
    J Psychiatr Res; 2008 May; 42(6):451-7. PubMed ID: 17628595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide for essential tremor.
    Ondo WG
    Clin Neuropharmacol; 2007; 30(6):345-9. PubMed ID: 18090459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam as adjunctive therapy for refractory anxiety disorders.
    Kinrys G; Worthington JJ; Wygant L; Nery F; Reese H; Pollack MH
    J Clin Psychiatry; 2007 Jul; 68(7):1010-3. PubMed ID: 17685735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.